Indications for continuous renal replacement therapy in sepsis

  • V. D’Intini
  • F. Gastaldon
  • C. Ronco
Conference paper


Sepsis continues to provide a major challenge to clinicians and, despite vast advancements in the understanding of pathways and mechanisms, the incidence of sepsis is increasing and the mortality rate remains unaffected, generating a considerable burden to health budgets worldwide [1]. Severe sepsis and septic shock are the most-common cause of multiple organ failure (MOF) [2]. MOF remains the most-frequent cause of death in patients admitted to the intensive care unit, with a mortality rate exceeding 50% [3]. The lung and liver are the most frequently involved organs in MOF. However, once acute renal failure (ARF) develops, the mortality exceeds 70% [4]. Unfortunately to date, there is no definitive therapy that conclusively treats sepsis and its deleterious complications with convincing success. Thus, once MOF is established the treatment is essentially supportive while awaiting for homeostasis to re-establish.


Septic Shock Severe Sepsis Acute Renal Failure Systemic Inflammatory Response Syndrome Multiple Organ Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Angus D, Linde-Zwirble W, Lidicker J, et al (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 29:1303–1309PubMedCrossRefGoogle Scholar
  2. 2.
    Beal AL, Cerra FB (1994) Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 19:226–233CrossRefGoogle Scholar
  3. 3.
    Baue AE, Durham R, Faist E (1998) Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battie? Shock 10:79–89PubMedCrossRefGoogle Scholar
  4. 4.
    Fry DE, Pearistein L, Fulton RI, et al (1980) Multiple system organ failure: The role of uncontrolled infection. Arch Surg 89:517–523Google Scholar
  5. 5.
    Baue AE (2000) A debate on the subject “Are SIRS and MODS important entities in the clinical evaluation of patients?” The con position. Shock 14:590–593PubMedCrossRefGoogle Scholar
  6. 6.
    Camussi G, Montmcchio G, Diminioni L, Dionigi R (1995) Septic shock: the unravelling of molecular mechanism. Nephrol Dial Transplant 10:1808–1813PubMedGoogle Scholar
  7. 7.
    Glauser MP, Zanetti G, Baumgartner JD, Cohen J (1991) Septic shock: pathogenesis. Lancet 338: 732–736PubMedCrossRefGoogle Scholar
  8. 8.
    Rodrick ML, Moss NM, Grbic JT, et al (1992) Effects of in vivo endotoxin infusions on in vitro cellular immune responses in humans. J Clin Immunol 12:440–450PubMedCrossRefGoogle Scholar
  9. 9.
    Michie HR, Spriggs DR, Manogue KR, et al (1988) Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104:280–286PubMedGoogle Scholar
  10. 10.
    Walters JM, Bessey PQ, Dinarello CA, et al (1986) Both inflammatory and endocrine mediators stimulate host responses to sepsis. Arch Surg 121:179–190CrossRefGoogle Scholar
  11. 11.
    Blackwell TS, Christman JW (1986) Sepsis and cytokines: current status. Br J Anaesth 77:110–117CrossRefGoogle Scholar
  12. 12.
    Antonelli M (1999) Sepsis and septic shock: pro-inflammatory or anti-inflammatory state? J Chemother 11:536–540PubMedGoogle Scholar
  13. 13.
    Cavaillon JM (2001) Pro- versus anti-inflammatory cytokines: myth or reality. Cell Mol Biol 47:695–702PubMedGoogle Scholar
  14. 14.
    Wheeler AP, Bemard GR (1999) Treating patients with severe sepsis. N Engl J Med 21:207–214CrossRefGoogle Scholar
  15. 15.
    Bone RC, Grodzin CJ, Balk RA (1997) Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235–143PubMedCrossRefGoogle Scholar
  16. 16.
    Muller Kobold AC, Tulleken JE, Zijlstra J, et al (2000) Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 26:883–892PubMedCrossRefGoogle Scholar
  17. 17.
    Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ (1996) Acute renal failure in intensive care units—causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 24:192–198PubMedCrossRefGoogle Scholar
  18. 18.
    Kellum JA, Angus DC, Johnson JP, et al (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28:29–37PubMedCrossRefGoogle Scholar
  19. 19.
    Canaud B, Mion C (1995) Extracorporeal treatment of acute renal failure: methods, indications, quantified and personalized therapeutic approach. Adv Nephrol 24:271–281Google Scholar
  20. 20.
    Uchino S, Bellomo R, Ronco C (2001) Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid-base balance. Intensive Care Med 7:1037–1043CrossRefGoogle Scholar
  21. 21.
    Silvester W (1997) Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis 30[Suppl 4]:S38-S43PubMedCrossRefGoogle Scholar
  22. 22.
    Cole L, Bellomo R, Joumois D, et al (2002) A phase 11 randomized controlled trial of continuous hemofiltration in sepsis. Crit Care Med. 30:100–106PubMedCrossRefGoogle Scholar
  23. 23.
    Yekebas EF, Eisenberger CF, Ohnesorge H et al (2001) Attenuation of sepsis-related inmiuno-paralysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 29:1423–1430PubMedCrossRefGoogle Scholar
  24. 24.
    Bellomo R, Kellum JA, Gandhi CR, et al (2000) The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161:1429–1436PubMedCrossRefGoogle Scholar
  25. 25.
    Ronco C, Bellomo R, Hömel P, et al (2000) Effects of different doses in continuous veno-venous hemodiafiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: 26–30PubMedCrossRefGoogle Scholar
  26. 26.
    Joumois D, Israel Biet D, Pouard P, et al (1996) High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 85:965–976CrossRefGoogle Scholar
  27. 27.
    Oudemans-van Straaten HM, Bosman RJ, van der Spoe JI, Zandstra DF (1999) Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 25:814–821CrossRefGoogle Scholar
  28. 28.
    Honore PM, Jamez J, Wauthier M, et al (1998) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581–3587CrossRefGoogle Scholar
  29. 29.
    Tetta C, Cavaillon JM, Schulze M, et al (1998) Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant 13:1458–1464PubMedCrossRefGoogle Scholar
  30. 30.
    Lee PA, Weger GW, Pryor RW, Matson JR (1998) Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 26:730–737PubMedCrossRefGoogle Scholar
  31. 31.
    Reeves JH, Butt WW, Shann F, Layton JE, et al (1999) Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 27:2096–2104PubMedCrossRefGoogle Scholar
  32. 32.
    Tetta C, Bellomo R, Brendolan A, et al (1999) Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill. Kidney Int 56[Supp72]:S15-S19CrossRefGoogle Scholar
  33. 33.
    Tetta C, Gianotti L, Cavaillon JM, et al (2000) Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med 28:1526–1533PubMedCrossRefGoogle Scholar
  34. 34.
    Ronco C, Brendolan A, Lonnemann G, et al (2002) A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 30:1250–1255PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • V. D’Intini
  • F. Gastaldon
  • C. Ronco

There are no affiliations available

Personalised recommendations